ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Innovation Pharmaceuticals Inc (CE)

Innovation Pharmaceuticals Inc (CE) (IPIX)

0.0001
0.00
(0.00%)
Closed December 21 3:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.0001
Bid
0.00
Ask
0.00
Volume
745,670
0.0001 Day's Range 0.0001
0.000001 52 Week Range 0.0195
Market Cap
Previous Close
0.0001
Open
0.0001
Last Trade
10000
@
0.0001
Last Trade Time
Financial Volume
US$ 75
VWAP
0.0001
Average Volume (3m)
348,059
Shares Outstanding
518,347,691
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-0.01
Revenue
-
Net Profit
-3.17M

About Innovation Pharmaceuticals Inc (CE)

An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer co... An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Carson City, Nevada, USA
Founded
-
Innovation Pharmaceuticals Inc (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker IPIX. The last closing price for Innovation Pharmaceuticals (CE) was US$0. Over the last year, Innovation Pharmaceuticals (CE) shares have traded in a share price range of US$ 0.000001 to US$ 0.0195.

Innovation Pharmaceuticals (CE) currently has 518,347,691 shares outstanding. The market capitalization of Innovation Pharmaceuticals (CE) is US$51,834.77 . Innovation Pharmaceuticals (CE) has a price to earnings ratio (PE ratio) of 0.00.

IPIX Latest News

IQST Has Catalysts On Deck That Expose A Valuation Disconnect of Roughly 100% - Here's Why That Gap Should Close

November 5, 2021 -- InvestorsHub NewsWire -- via Hawk Point Media -- Benzinga iQSTEL Inc.’s (OTCQX:IQST) market cap of $62M is absurdly low. In fact, 2021 revenues, if they...

CEO Presenting on the Emerging Growth Conference on October 13 Register Now

CEO Presenting on the Emerging Growth Conference on October 13 Register Now Niche Companies in Technology, Biotech / Pharma, FinTech, Exploration, Wellness, and more in Attendance. Miami, Florida...

CEO's Presenting on the Emerging Growth Conference 17 TODAY.  Register Now

CEO's Presenting on the Emerging Growth Conference 17 TODAY.  Register Now   Niche Companies in Technology, Biotech / Pharma, FinTech, Exploration, Wellness, and more in...

CLS Holdings, (OTCQB: CLSH) New Joint Venture $19 million Sales 61% Growth

CLS Holdings, (OTCQB: CLSH) New Joint Venture $19 million Sales 61% Growth   Miami, FL--(September 28, 2021) – EmergingGrowth.com, a leading independent small cap media portal...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0002-66.66666666670.00030.00030.00012280840.00026697CS
4-0.0001-500.00020.01860.00011626520.00029274CS
12-0.0002-66.66666666670.00030.01870.00013480590.00040829CS
26-0.0011-91.66666666670.00120.01871.0E-62618610.00044554CS
52-0.0049-980.0050.01951.0E-64163270.00669418CS
156-0.0593-99.83164983160.05940.06491.0E-65422180.02411137CS
260-0.0649-99.84615384620.0650.651.0E-612789190.16905901CS

IPIX - Frequently Asked Questions (FAQ)

What is the current Innovation Pharmaceuticals (CE) share price?
The current share price of Innovation Pharmaceuticals (CE) is US$ 0.0001
How many Innovation Pharmaceuticals (CE) shares are in issue?
Innovation Pharmaceuticals (CE) has 518,347,691 shares in issue
What is the market cap of Innovation Pharmaceuticals (CE)?
The market capitalisation of Innovation Pharmaceuticals (CE) is USD 51.83k
What is the 1 year trading range for Innovation Pharmaceuticals (CE) share price?
Innovation Pharmaceuticals (CE) has traded in the range of US$ 0.000001 to US$ 0.0195 during the past year
What is the reporting currency for Innovation Pharmaceuticals (CE)?
Innovation Pharmaceuticals (CE) reports financial results in USD
What is the latest annual profit for Innovation Pharmaceuticals (CE)?
The latest annual profit of Innovation Pharmaceuticals (CE) is USD -3.17M
What is the registered address of Innovation Pharmaceuticals (CE)?
The registered address for Innovation Pharmaceuticals (CE) is 701 S. CARSON STREET, SUITE 200, CARSON CITY, NEVADA, 89701
What is the Innovation Pharmaceuticals (CE) website address?
The website address for Innovation Pharmaceuticals (CE) is www.ipharminc.com
Which industry sector does Innovation Pharmaceuticals (CE) operate in?
Innovation Pharmaceuticals (CE) operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ELIQQElectriq Power Holdings Inc (CE)
US$ 0.10
(99,900.00%)
100
GNTLFGenetic Technologies Ltd (PK)
US$ 1.00
(90,809.09%)
100
VIVEViveve Medical Inc (CE)
US$ 0.0003
(29,900.00%)
7.33k
BTIMBoatim Inc (CE)
US$ 0.0002
(19,900.00%)
799
CLVRClever Leaves Holdings Inc (CE)
US$ 0.0002
(19,900.00%)
592
RAASYCloopen Group Holding Limited (CE)
US$ 0.000001
(-100.00%)
214
EWGFFEat Well Investment Group Inc (CE)
US$ 0.000001
(-100.00%)
47.01k
SOLBFSoLVBL Solutions Inc (CE)
US$ 0.000001
(-99.99%)
10k
HAVLFHavn Life Sciences Inc (CE)
US$ 0.000001
(-99.98%)
4.02k
ENDRFEndor AG (GM)
US$ 0.0001
(-99.98%)
560
HMBLHUMBL Inc (PK)
US$ 0.00095
(5.56%)
344.89M
PHILPHI Group Inc (PK)
US$ 0.0003
(0.00%)
312.21M
PLPLPlandai Biotechnology Inc (PK)
US$ 0.0001
(0.00%)
215.71M
RDARRaadr Inc (PK)
US$ 0.0014
(16.67%)
174.96M
CHNVFChina Youzan Ltd (PK)
US$ 0.0177
(10.63%)
100M

IPIX Discussion

View Posts
TheHound TheHound 2 hours ago
News! https://www.globenewswire.com/fr/news-release/2016/12/22/901271/0/en/Cellceutix-Wishes-Shareholders-Happy-Holidays-Prepares-for-2017-Focused-on-Partnerships.html




Albeit old news. Very old news.
👍️0
williamssc williamssc 2 days ago
I doubt Leo wants the government looking at his books. What we need is sunlight.
👍️0
loanranger loanranger 2 days ago
"Big Z, we have no idea what he's doing behind the scenes"
Sure we do....he's out helping OJ find the real killers.
👍️ 1
PJ007 PJ007 3 days ago
Big Z, we have no idea what he's doing behind the scenes.....as a long time shareholder, i believe he owes it to his shareholder's to tell us.......
👍 1
zandant zandant 3 days ago
Reading your post, I thought it was April 1st instead of December 18th. Do you really think Ehrlich would lift a finger (other than the middle finger towards the shareholders) to pull this mess out of the gutter? He has abandoned what is left of his one-man operation just like he abandoned the shareholders long ago.
👍️0
PJ007 PJ007 4 days ago
Why can't IPIX receive a similar grant for Brilacidin with all the studies that have taken place. I really hope that Leo has applied for one!!!!!
https://finance.yahoo.com/news/marker-therapeutics-awarded-9-5-120000070.html
👍️ 1
realscottsmith realscottsmith 1 week ago
The grave just happens to be sunbathing with a fruity drink poolside in Boca.
👍️ 1
JTORENCE JTORENCE 1 week ago
The headstone has been ordered, just waiting for delivery and the crew to show up to place it on the grave. "RIP" IPIX, you have taken peoples had earned dollars to the grave with you.
👍️0
zandant zandant 2 weeks ago
And once the Court of Appeal decision comes down, it will finally be buried.
👍 1
TheHound TheHound 2 weeks ago
IPIX is dead!
👍️0
sunspotter sunspotter 2 weeks ago
Nope. He sleeps like a baby in a feather bedded mattress that IPIX shareholders paid for.

When he’s not lounging by his Florida mansion’s pool, that is.
👍️0
JTORENCE JTORENCE 2 weeks ago
zandant Hopefully he now sleeps with the "fishes"
👍️0
threebabiesbusy threebabiesbusy 2 weeks ago
What a putz!
👍️ 1
zandant zandant 2 weeks ago
The CEO has also gone missing.....
👍️0
threebabiesbusy threebabiesbusy 2 weeks ago
Missing the group of long timers.
👍️0
duchamp duchamp 2 weeks ago
Truly disheartening!
👍️0
sunspotter sunspotter 2 weeks ago
He hasn't posted for a while:

https://investorshub.advfn.com/boards/profileb.aspx?user=70157

Which is a shame.
👍️0
threebabiesbusy threebabiesbusy 2 weeks ago
Minnie are you still around?
👍️0
threebabiesbusy threebabiesbusy 2 weeks ago
Hopefully when we least expect it!
👍️ 1
zandant zandant 2 weeks ago
Will anyone ever hear from Ehrlich again?
👍️0
zandant zandant 2 weeks ago
Point your anger over what must be a significant loss at Ehrlich, "dude." Still believing that this garbage is hidden treasure is what's truly sick.
👍️0
threebabiesbusy threebabiesbusy 2 weeks ago
Will this ever come back to life? hmmmmm
👍️0
PJ007 PJ007 2 weeks ago
Dude, the posts by you guys are pathetic. Why are you so concerned about my investment or any one else's.....this is borderline sick.....
💯 1
zandant zandant 2 weeks ago
Why do you care about a poster on a message board? Maybe you should focus on your hero Ehrlich and find out where he is and ask him why you have lost your investment. Ask him what happened with the Laser Boys big laser beam splash.
👍️ 1
sunspotter sunspotter 2 weeks ago
“ $4 million wasted on the Laser Boys should be on Ehrlich's failed company's virtual headstone”

I suspect you’ll find a goodly portion of that $4 million poolside at Ehrlich’s Florida mansion.
👍️0
PJ007 PJ007 2 weeks ago
We get it, IPIX is dead, Ehrlich is a crook. Why do you guys keep coming here???? I don't get it.....
👍️0
zandant zandant 2 weeks ago
Even Ehrlich, the biggest lying hypster around, has abandoned this sunken ship. Once the appeal is lost, the bones of IPIX will turn to dust...and the $4 million wasted on the Laser Boys should be on Ehrlich's failed company's virtual headstone.
👍️ 1
sunspotter sunspotter 2 weeks ago
“Quite a shame”

But utterly predictable. Indeed utterly predicted.
👍️0
1oldprof 1oldprof 3 weeks ago
I cannot believe there are still people in this stock. This company is dead. Quite a shame, really
👍️ 1
TheHound TheHound 3 weeks ago
The one question…. LOL. Fuck no. U know that. Shit. Core shares here when I sold just before the release of the COVID results were invested in bitcoin/alt/meme coins. I 10x that and am currently up 5x this bull run which is just getting started. This shit is and will always be chump change compared to crypto.

Poor bastards. Shake that bag.
👍️0
loanranger loanranger 3 weeks ago
I still have mine!
👍️0
leavetheguntakethecannolis leavetheguntakethecannolis 3 weeks ago
The one question that results in silence. Blissful silence.
👍 2 😂 1
PJ007 PJ007 3 weeks ago
Hey Hound, as per your old posts, you were a huge investor???? Do you still own your shares?????
👍 1 😄 1
TheHound TheHound 3 weeks ago
While we wait…Any new B-Petri dish papers published lately?

Petri dish studies, also known as in vitro experiments, often lead to false hope because they are conducted in highly controlled laboratory environments that do not fully replicate the complexity of living organisms. Here are the key reasons for this:

1. Oversimplified Conditions
In a Petri dish, cells are isolated and grown in artificial environments with carefully controlled nutrients, pH, and temperature. This does not mimic the intricate systems and interactions that occur in a living organism. A treatment that works on isolated cells may behave very differently in the body.

2. Lack of Systemic Factors
The body is a dynamic system with multiple interacting components, including the immune system, hormones, and metabolism. A treatment might show promise in a Petri dish but fail when introduced to the complexities of a whole organism.

3. Doses and Delivery
In in vitro studies, substances can be applied directly to cells at specific concentrations. In the body, reaching the target cells in the same way can be much more difficult due to issues with absorption, distribution, metabolism, and excretion.

4. Overextrapolation
Positive results in in vitro studies are sometimes overhyped in the media or even by researchers, leading to unrealistic expectations about how soon a discovery might lead to effective treatments for humans.

5. Lack of Whole-Body Toxicity Data
A compound might kill harmful cells in a Petri dish but could be toxic to normal cells or organs in a living organism. The safety profile often cannot be assessed until in vivo studies (in animals or humans) are conducted.

Example

Many cancer drugs have shown promise in killing tumor cells in a Petri dish but fail in clinical trials due to poor efficacy in the body or unacceptable side effects. Similarly, certain antioxidants or supplements that protect cells in in vitro studies have not demonstrated significant health benefits when tested in humans.

Conclusion

While Petri dish studies are valuable for initial insights and screening, they are only the first step in a long process of research. Their findings must be validated through animal studies, human trials, and real-world applications before they can lead to effective and safe treatments.

Universities publish a significant amount of research involving Petri dishes (in vitro studies) because these experiments are foundational to scientific inquiry and serve important purposes in advancing knowledge and innovation. Here’s why:

1. Early-Stage Discovery

• In vitro studies are often the first step in investigating new ideas, testing hypotheses, and identifying potential mechanisms in biology and medicine.

• They provide a cost-effective and controlled way to test theories before advancing to more complex and expensive animal or human studies.

2. Building a Knowledge Base

• Universities prioritize generating fundamental knowledge, even if it doesn’t immediately lead to clinical applications.

• Petri dish studies contribute valuable insights into how cells, molecules, and organisms work at a basic level.

3. Low-Risk and Ethical Feasibility

• Using Petri dishes avoids ethical and logistical complications involved in animal or human studies.

• Early-stage research involving living organisms requires more rigorous oversight and approval, making in vitro studies an accessible starting point.

4. Funding and Academic Metrics

• Grant agencies often fund exploratory research to develop preliminary data for larger projects. Petri dish studies are a common source of this early data.

• Academic researchers are often measured by their publication output, so publishing in vitro findings helps meet performance and funding expectations.

5. Proof of Concept

• Researchers use Petri dish experiments to show whether an idea has potential. These results can justify follow-up studies in animals or humans, securing further funding or collaboration.

• Journals often accept such studies because they are a crucial step in the pipeline of scientific discovery.

6. Incremental Nature of Science

• Science progresses in small, incremental steps. Petri dish studies often represent one of these steps in understanding complex biological phenomena.

• Even if a study doesn’t lead directly to a cure or breakthrough, it may provide a building block for future discoveries.

7. Ease of Reproducibility

• Petri dish studies are typically easier to replicate compared to animal or human studies, making them valuable for establishing reproducible science.

Challenges and Context

While universities publish a lot of Petri dish research, it is essential for scientists, journals, and the media to clearly communicate the limitations of such studies. Misrepresentation of preliminary findings as groundbreaking breakthroughs can lead to false hope, but this is not inherent to the research itself—it’s often a matter of how the results are presented or interpreted.
👍️0
loanranger loanranger 4 weeks ago
IPIX has until 1/19 to respond to the Cummings brief filed on 11/12.
Unfortunately we don't get to see what these briefs say.

This is the last hard fact I've seen...from the original case:
"08/23/2024 ORDER: of Post Judgment Security
..II. ALTERNATIVE SECURITY
In accordance with General Laws c. 223, sec. 86A, Innovation shall obtain and provide within thirty (30) days of this Order a bond payment to Cummings with sureties to be approved by this Court conditioned to pay Cummings the amount of at least $1,375,811.36, within thirty (30) days of the date when execution may issue upon judgment, which bond shall be filed with the clerk after its approval by the Court."

Would be interesting to know if that was done....I thought the appeal was contingent on it.
👍️ 2
Cassius Longinus Cassius Longinus 4 weeks ago
Now delayed until January 19th?
👍️0
TheHound TheHound 4 weeks ago
oooooooooooooooooo2 x 0 is zero. It’s dead.
👍️0
AKBrakeman AKBrakeman 4 weeks ago
We're holding at .oooooooooooooooooo2.  Not dead yet! 
👍 1
TheHound TheHound 4 weeks ago
IPIX is dead. Not trading. Zero value.

4 trillion shares traded TODAY so far. 1/4 Billion dollars. Dump the remaining buck left in your bag and make100x ur money for a $100 steak dinner at Outback! Hell! I’m buyin. Let’s go!

Poor bastards.

👍️0
TheHound TheHound 4 weeks ago
LOL. Shake that bag.
👍️0
PJ007 PJ007 1 month ago
I have to admit that I agree with you!!!!!!
👍 1
loanranger loanranger 1 month ago
"he's due to update his shareholders....."

What a ridiculous comment. Due? He's been OBLIGATED to update his shareholders (and everyone else) since the 10Q that was filed A YEAR AGO yesterday and he hasn't.
He continues to show himself to be irresponsible at the very least....crooked is probably more fitting.

You're lucky you haven't heard from him. It would only add fuel to your misguided beliefs.
👍️ 4
PJ007 PJ007 1 month ago
I'd rather hear from Leo, he's due to update his shareholders.....
👍️0
MackG MackG 1 month ago
Absolutely, unless it's a quiet period that has been dragging on. I would love to hear from frenchbroad right about now.
👍 1
PJ007 PJ007 1 month ago
That's a great question that only Leo can answer. I really wish he would address his shareholders......
👍 1
MackG MackG 1 month ago
Has or will IPIX be compensated by the... many companies who have included Brilacidin in their patent applications?
Have these companies entered into compensation arrangements or agreements with IPIX?
Can anyone knowledgable in this area enlighten me? TIA
👍 2
MackG MackG 1 month ago
Brilacidin has been included in many patent applications. Have these companies done this after entering into compensation arrangements or agreements with IPIX?
Can anyone knowledgable in this area enlighten me? TIA
👍 1
TheHound TheHound 1 month ago
Shake that bag.
👍️ 1
leavetheguntakethecannolis leavetheguntakethecannolis 1 month ago
IPIX isn't dead.
👍 2
PJ007 PJ007 1 month ago
Humanigen published this patent on Sept 26, it mentions Brilacidin 50 times. Perhaps Leo does have something up his sleeve.....

https://ppubs.uspto.gov/dirsearch-public/print/downloadBasicPdf/20240317846?requestToken=eyJzdWIiOiIyZmFjYWE1YS1jMWFmLTQ4NjItYmE0ZS00MWFlYjZmODJjMzciLCJ2ZXIiOiI1OWRjOTJlMS0zY2JlLTQxOWEtYjg3Ni1lZDk3ZDZhNWZhOTkiLCJleHAiOjB9
👍 3

Your Recent History

Delayed Upgrade Clock